23andMe Holding ME Stock
23andMe Holding Price Chart
23andMe Holding ME Financial and Trading Overview
23andMe Holding stock price | 0.44 USD |
Previous Close | 1.86 USD |
Open | 1.85 USD |
Bid | 0 USD x 1800 |
Ask | 0 USD x 1800 |
Day's Range | 1.83 - 1.92 USD |
52 Week Range | 1.74 - 6.31 USD |
Volume | 2.39M USD |
Avg. Volume | 2.06M USD |
Market Cap | 871.77M USD |
Beta (5Y Monthly) | 1.36515 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.11 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.5 USD |
ME Valuation Measures
Enterprise Value | 556.39M USD |
Trailing P/E | N/A |
Forward P/E | -2.953125 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.9108648 |
Price/Book (mrq) | 1.2209302 |
Enterprise Value/Revenue | 1.858 |
Enterprise Value/EBITDA | -1.906 |
Trading Information
23andMe Holding Stock Price History
Beta (5Y Monthly) | 1.36515 |
52-Week Change | -24.70% |
S&P500 52-Week Change | 20.43% |
52 Week High | 6.31 USD |
52 Week Low | 1.74 USD |
50-Day Moving Average | 2.04 USD |
200-Day Moving Average | 2.56 USD |
ME Share Statistics
Avg. Volume (3 month) | 2.06M USD |
Avg. Daily Volume (10-Days) | 3.08M USD |
Shares Outstanding | 293.08M |
Float | 290.15M |
Short Ratio | 9.5 |
% Held by Insiders | 5.07% |
% Held by Institutions | 46.86% |
Shares Short | 22.81M |
Short % of Float | 8.06% |
Short % of Shares Outstanding | 4.93% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | -104.062% |
Operating Margin (ttm) | -108.18% |
Gross Margin | 44.90% |
EBITDA Margin | -97.47% |
Management Effectiveness
Return on Assets (ttm) | -19.33% |
Return on Equity (ttm) | -38.24% |
Income Statement
Revenue (ttm) | 299.49M USD |
Revenue Per Share (ttm) | 0.66 USD |
Quarterly Revenue Growth (yoy) | -8.099% |
Gross Profit (ttm) | N/A |
EBITDA | -291940000 USD |
Net Income Avi to Common (ttm) | -311656000 USD |
Diluted EPS (ttm) | -0.65 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 386.85M USD |
Total Cash Per Share (mrq) | 0.84 USD |
Total Debt (mrq) | 85.3M USD |
Total Debt/Equity (mrq) | 11.95 USD |
Current Ratio (mrq) | 2.844 |
Book Value Per Share (mrq) | 1.548 |
Cash Flow Statement
Operating Cash Flow (ttm) | -165390000 USD |
Levered Free Cash Flow (ttm) | -54419876 USD |
Profile of 23andMe Holding
Country | United States |
State | CA |
City | South San Francisco |
Address | 349 Oyster Point Boulevard |
ZIP | 94080 |
Phone | (650) 938-6300 |
Website | https://www.23andme.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 769 |
23andMe Holding Co. operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications; and Lemonaid telehealth platform, patients can access affiliated licensed healthcare professionals for medical consultation and treatment for several common conditions, as well as research services. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline plc to leverage genetic insights to validate, develop, and commercialize drugs. The company was founded in 2006 and is headquartered in South San Francisco, California.
Q&A For 23andMe Holding Stock
What is a current ME stock price?
23andMe Holding ME stock price today per share is 0.44 USD.
How to purchase 23andMe Holding stock?
You can buy ME shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for 23andMe Holding?
The stock symbol or ticker of 23andMe Holding is ME.
Which industry does the 23andMe Holding company belong to?
The 23andMe Holding industry is Diagnostics & Research.
How many shares does 23andMe Holding have in circulation?
The max supply of 23andMe Holding shares is 482.92M.
What is 23andMe Holding Price to Earnings Ratio (PE Ratio)?
23andMe Holding PE Ratio is now.
What was 23andMe Holding earnings per share over the trailing 12 months (TTM)?
23andMe Holding EPS is -1.11 USD over the trailing 12 months.
Which sector does the 23andMe Holding company belong to?
The 23andMe Holding sector is Healthcare.
23andMe Holding ME included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}